CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo
Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that hu...
Gespeichert in:
Veröffentlicht in: | Journal of virology 2017-01, Vol.91 (1) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | |
container_title | Journal of virology |
container_volume | 91 |
creator | Teng, Ooiean Chen, Szu-Ting Hsu, Tsui-Ling Sia, Sin Fun Cole, Suzanne Valkenburg, Sophie A Hsu, Tzu-Yun Zheng, Jian Teddy Tu, Wenwei Bruzzone, Roberto Peiris, Joseph Sriyal Malik Hsieh, Shie-Liang Yen, Hui-Ling |
description | Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that human C-type lectin domain family 5 member A (CLEC5A) interacts with the hemagglutinin protein of influenza viruses expressed on lentiviral pseudoparticles through lectin screening. Silencing CLEC5A gene expression, blocking influenza-CLEC5A interactions with anti-CLEC5A antibodies, or dampening CLEC5A-mediated signaling using a spleen tyrosine kinase inhibitor consistently reduced the levels of proinflammatory cytokines produced by human macrophages without affecting the replication of influenza A viruses of different subtypes. Infection of bone marrow-derived macrophages from CLEC5A-deficient mice showed reduced levels of tumor necrosis factor alpha (TNF-α) and IP-10 but elevated alpha interferon (IFN-α) compared to those of wild-type mice. The heightened type I IFN response in the macrophages of CLEC5A-deficient mice was associated with upregulated TLR3 mRNA after treatment with double-stranded RNA. Upon lethal challenges with a recombinant H5N1 virus, CLEC5A-deficient mice showed reduced levels of proinflammatory cytokines, decreased immune cell infiltration in the lungs, and improved survival compared to the wild-type mice, despite comparable viral loads noted throughout the course of infection. The survival difference was more prominent at a lower dose of inoculum. Our results suggest that CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo and may be considered a therapeutic target in combination with effective antivirals. Well-orchestrated host responses together with effective viral clearance are critical for optimal clinical outcome after influenza infections.
Multiple pattern recognition receptors work in synergy to sense viral RNA or proteins synthesized during influenza replication and mediate host responses for viral control. Well-orchestrated host responses may help to maintain the inflammatory response to minimize tissue damage while inducing an effective adaptive immune response for viral clearance. We identified that CLEC5A, a C-type lectin receptor which has previously been reported to mediate flavivirus-induced inflammatory responses, enhanced induction of proinflammatory cyto |
doi_str_mv | 10.1128/JVI.01813-16 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5165214</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1868304088</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-722ab3f2ffcdc06e720f90313e73cc5c57fe264c47254a207686aa9730246f7a3</originalsourceid><addsrcrecordid>eNqNkc2LFDEQxYMo7uzqzbPk6MFe8530RViacR2ZRRFdvIVMprIT6U7GTnphPPi32_vhojdPBfVe_ajHQ-gFJaeUMvPmw-XqlFBDeUPVI7SgpDWNlFQ8RgtCGGskN9-O0HEp3wmhQijxFB0xrVspuFigX9162cmz5gK20VXY4mXaueRhgFRxDrjuAK9S6N0wuJrHA_4MZZ9TARwTvjhAn-MWd9D3BXc51TFupgoF13x7NUH66fBlHKeCP7m6y1eQoo_1MKvz-jo_Q0-C6ws8v58n6Ou75ZfufbP-eL7qztaNF1TXRjPmNjywEPzWEwWakdASTjlo7r30UgdgSnihmRSOEa2Mcq7VnDChgnb8BL294-6nzQBbP6cbXW_3YxzceLDZRfuvkuLOXuVrK6mSjIoZ8OoeMOYfE5Rqh1j8nNslyFOx1CjDiSDG_IeVi7Ztjbyhvr6z-jGXMkJ4-IgSe9Oundu1t-1aqmb7y79TPJj_1Ml_A0_uoTU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1834999854</pqid></control><display><type>article</type><title>CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo</title><source>MEDLINE</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Teng, Ooiean ; Chen, Szu-Ting ; Hsu, Tsui-Ling ; Sia, Sin Fun ; Cole, Suzanne ; Valkenburg, Sophie A ; Hsu, Tzu-Yun ; Zheng, Jian Teddy ; Tu, Wenwei ; Bruzzone, Roberto ; Peiris, Joseph Sriyal Malik ; Hsieh, Shie-Liang ; Yen, Hui-Ling</creator><contributor>Perlman, Stanley</contributor><creatorcontrib>Teng, Ooiean ; Chen, Szu-Ting ; Hsu, Tsui-Ling ; Sia, Sin Fun ; Cole, Suzanne ; Valkenburg, Sophie A ; Hsu, Tzu-Yun ; Zheng, Jian Teddy ; Tu, Wenwei ; Bruzzone, Roberto ; Peiris, Joseph Sriyal Malik ; Hsieh, Shie-Liang ; Yen, Hui-Ling ; Perlman, Stanley</creatorcontrib><description>Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that human C-type lectin domain family 5 member A (CLEC5A) interacts with the hemagglutinin protein of influenza viruses expressed on lentiviral pseudoparticles through lectin screening. Silencing CLEC5A gene expression, blocking influenza-CLEC5A interactions with anti-CLEC5A antibodies, or dampening CLEC5A-mediated signaling using a spleen tyrosine kinase inhibitor consistently reduced the levels of proinflammatory cytokines produced by human macrophages without affecting the replication of influenza A viruses of different subtypes. Infection of bone marrow-derived macrophages from CLEC5A-deficient mice showed reduced levels of tumor necrosis factor alpha (TNF-α) and IP-10 but elevated alpha interferon (IFN-α) compared to those of wild-type mice. The heightened type I IFN response in the macrophages of CLEC5A-deficient mice was associated with upregulated TLR3 mRNA after treatment with double-stranded RNA. Upon lethal challenges with a recombinant H5N1 virus, CLEC5A-deficient mice showed reduced levels of proinflammatory cytokines, decreased immune cell infiltration in the lungs, and improved survival compared to the wild-type mice, despite comparable viral loads noted throughout the course of infection. The survival difference was more prominent at a lower dose of inoculum. Our results suggest that CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo and may be considered a therapeutic target in combination with effective antivirals. Well-orchestrated host responses together with effective viral clearance are critical for optimal clinical outcome after influenza infections.
Multiple pattern recognition receptors work in synergy to sense viral RNA or proteins synthesized during influenza replication and mediate host responses for viral control. Well-orchestrated host responses may help to maintain the inflammatory response to minimize tissue damage while inducing an effective adaptive immune response for viral clearance. We identified that CLEC5A, a C-type lectin receptor which has previously been reported to mediate flavivirus-induced inflammatory responses, enhanced induction of proinflammatory cytokines and chemokines in myeloid cells after influenza infections. CLEC5A-deficient mice infected with influenza virus showed reduced inflammation in the lungs and improved survival compared to that of the wild-type mice despite comparable viral loads. The survival difference was more prominent at a lower dose of inoculum. Collectively, our results suggest that dampening CLEC5A-mediated inflammatory responses in myeloid cells reduces immunopathogenesis after influenza infections.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.01813-16</identifier><identifier>PMID: 27795434</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Antibodies - pharmacology ; Chemokine CXCL10 - genetics ; Chemokine CXCL10 - immunology ; Gene Expression Regulation ; Hemagglutinin Glycoproteins, Influenza Virus - genetics ; Hemagglutinin Glycoproteins, Influenza Virus - immunology ; Host-Pathogen Interactions ; Humans ; Influenza A Virus, H1N1 Subtype - growth & development ; Influenza A Virus, H1N1 Subtype - immunology ; Influenza A Virus, H1N1 Subtype - pathogenicity ; Influenza A Virus, H5N1 Subtype - growth & development ; Influenza A Virus, H5N1 Subtype - immunology ; Influenza A Virus, H5N1 Subtype - pathogenicity ; Interferon-alpha - genetics ; Interferon-alpha - immunology ; Lectins, C-Type - antagonists & inhibitors ; Lectins, C-Type - genetics ; Lectins, C-Type - immunology ; Lentivirus - genetics ; Lentivirus - immunology ; Lung - drug effects ; Lung - immunology ; Lung - virology ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - virology ; Macrophages, Alveolar - drug effects ; Macrophages, Alveolar - immunology ; Macrophages, Alveolar - virology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Orthomyxoviridae ; Orthomyxoviridae Infections - genetics ; Orthomyxoviridae Infections - immunology ; Orthomyxoviridae Infections - mortality ; Orthomyxoviridae Infections - virology ; Pathogenesis and Immunity ; Primary Cell Culture ; Protein Binding ; Protein Isoforms - genetics ; Protein Isoforms - immunology ; Receptors, Cell Surface - antagonists & inhibitors ; Receptors, Cell Surface - genetics ; Receptors, Cell Surface - immunology ; RNA, Small Interfering - genetics ; RNA, Small Interfering - metabolism ; Survival Analysis ; Toll-Like Receptor 3 - genetics ; Toll-Like Receptor 3 - immunology ; Tumor Necrosis Factor-alpha - genetics ; Tumor Necrosis Factor-alpha - immunology</subject><ispartof>Journal of virology, 2017-01, Vol.91 (1)</ispartof><rights>Copyright © 2016 Teng et al.</rights><rights>Copyright © 2016 Teng et al. 2016 Teng et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-722ab3f2ffcdc06e720f90313e73cc5c57fe264c47254a207686aa9730246f7a3</citedby><cites>FETCH-LOGICAL-c417t-722ab3f2ffcdc06e720f90313e73cc5c57fe264c47254a207686aa9730246f7a3</cites><orcidid>0000-0003-2493-3609</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165214/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165214/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27795434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Perlman, Stanley</contributor><creatorcontrib>Teng, Ooiean</creatorcontrib><creatorcontrib>Chen, Szu-Ting</creatorcontrib><creatorcontrib>Hsu, Tsui-Ling</creatorcontrib><creatorcontrib>Sia, Sin Fun</creatorcontrib><creatorcontrib>Cole, Suzanne</creatorcontrib><creatorcontrib>Valkenburg, Sophie A</creatorcontrib><creatorcontrib>Hsu, Tzu-Yun</creatorcontrib><creatorcontrib>Zheng, Jian Teddy</creatorcontrib><creatorcontrib>Tu, Wenwei</creatorcontrib><creatorcontrib>Bruzzone, Roberto</creatorcontrib><creatorcontrib>Peiris, Joseph Sriyal Malik</creatorcontrib><creatorcontrib>Hsieh, Shie-Liang</creatorcontrib><creatorcontrib>Yen, Hui-Ling</creatorcontrib><title>CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that human C-type lectin domain family 5 member A (CLEC5A) interacts with the hemagglutinin protein of influenza viruses expressed on lentiviral pseudoparticles through lectin screening. Silencing CLEC5A gene expression, blocking influenza-CLEC5A interactions with anti-CLEC5A antibodies, or dampening CLEC5A-mediated signaling using a spleen tyrosine kinase inhibitor consistently reduced the levels of proinflammatory cytokines produced by human macrophages without affecting the replication of influenza A viruses of different subtypes. Infection of bone marrow-derived macrophages from CLEC5A-deficient mice showed reduced levels of tumor necrosis factor alpha (TNF-α) and IP-10 but elevated alpha interferon (IFN-α) compared to those of wild-type mice. The heightened type I IFN response in the macrophages of CLEC5A-deficient mice was associated with upregulated TLR3 mRNA after treatment with double-stranded RNA. Upon lethal challenges with a recombinant H5N1 virus, CLEC5A-deficient mice showed reduced levels of proinflammatory cytokines, decreased immune cell infiltration in the lungs, and improved survival compared to the wild-type mice, despite comparable viral loads noted throughout the course of infection. The survival difference was more prominent at a lower dose of inoculum. Our results suggest that CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo and may be considered a therapeutic target in combination with effective antivirals. Well-orchestrated host responses together with effective viral clearance are critical for optimal clinical outcome after influenza infections.
Multiple pattern recognition receptors work in synergy to sense viral RNA or proteins synthesized during influenza replication and mediate host responses for viral control. Well-orchestrated host responses may help to maintain the inflammatory response to minimize tissue damage while inducing an effective adaptive immune response for viral clearance. We identified that CLEC5A, a C-type lectin receptor which has previously been reported to mediate flavivirus-induced inflammatory responses, enhanced induction of proinflammatory cytokines and chemokines in myeloid cells after influenza infections. CLEC5A-deficient mice infected with influenza virus showed reduced inflammation in the lungs and improved survival compared to that of the wild-type mice despite comparable viral loads. The survival difference was more prominent at a lower dose of inoculum. Collectively, our results suggest that dampening CLEC5A-mediated inflammatory responses in myeloid cells reduces immunopathogenesis after influenza infections.</description><subject>Animals</subject><subject>Antibodies - pharmacology</subject><subject>Chemokine CXCL10 - genetics</subject><subject>Chemokine CXCL10 - immunology</subject><subject>Gene Expression Regulation</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - genetics</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - immunology</subject><subject>Host-Pathogen Interactions</subject><subject>Humans</subject><subject>Influenza A Virus, H1N1 Subtype - growth & development</subject><subject>Influenza A Virus, H1N1 Subtype - immunology</subject><subject>Influenza A Virus, H1N1 Subtype - pathogenicity</subject><subject>Influenza A Virus, H5N1 Subtype - growth & development</subject><subject>Influenza A Virus, H5N1 Subtype - immunology</subject><subject>Influenza A Virus, H5N1 Subtype - pathogenicity</subject><subject>Interferon-alpha - genetics</subject><subject>Interferon-alpha - immunology</subject><subject>Lectins, C-Type - antagonists & inhibitors</subject><subject>Lectins, C-Type - genetics</subject><subject>Lectins, C-Type - immunology</subject><subject>Lentivirus - genetics</subject><subject>Lentivirus - immunology</subject><subject>Lung - drug effects</subject><subject>Lung - immunology</subject><subject>Lung - virology</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - virology</subject><subject>Macrophages, Alveolar - drug effects</subject><subject>Macrophages, Alveolar - immunology</subject><subject>Macrophages, Alveolar - virology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Orthomyxoviridae</subject><subject>Orthomyxoviridae Infections - genetics</subject><subject>Orthomyxoviridae Infections - immunology</subject><subject>Orthomyxoviridae Infections - mortality</subject><subject>Orthomyxoviridae Infections - virology</subject><subject>Pathogenesis and Immunity</subject><subject>Primary Cell Culture</subject><subject>Protein Binding</subject><subject>Protein Isoforms - genetics</subject><subject>Protein Isoforms - immunology</subject><subject>Receptors, Cell Surface - antagonists & inhibitors</subject><subject>Receptors, Cell Surface - genetics</subject><subject>Receptors, Cell Surface - immunology</subject><subject>RNA, Small Interfering - genetics</subject><subject>RNA, Small Interfering - metabolism</subject><subject>Survival Analysis</subject><subject>Toll-Like Receptor 3 - genetics</subject><subject>Toll-Like Receptor 3 - immunology</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc2LFDEQxYMo7uzqzbPk6MFe8530RViacR2ZRRFdvIVMprIT6U7GTnphPPi32_vhojdPBfVe_ajHQ-gFJaeUMvPmw-XqlFBDeUPVI7SgpDWNlFQ8RgtCGGskN9-O0HEp3wmhQijxFB0xrVspuFigX9162cmz5gK20VXY4mXaueRhgFRxDrjuAK9S6N0wuJrHA_4MZZ9TARwTvjhAn-MWd9D3BXc51TFupgoF13x7NUH66fBlHKeCP7m6y1eQoo_1MKvz-jo_Q0-C6ws8v58n6Ou75ZfufbP-eL7qztaNF1TXRjPmNjywEPzWEwWakdASTjlo7r30UgdgSnihmRSOEa2Mcq7VnDChgnb8BL294-6nzQBbP6cbXW_3YxzceLDZRfuvkuLOXuVrK6mSjIoZ8OoeMOYfE5Rqh1j8nNslyFOx1CjDiSDG_IeVi7Ztjbyhvr6z-jGXMkJ4-IgSe9Oundu1t-1aqmb7y79TPJj_1Ml_A0_uoTU</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Teng, Ooiean</creator><creator>Chen, Szu-Ting</creator><creator>Hsu, Tsui-Ling</creator><creator>Sia, Sin Fun</creator><creator>Cole, Suzanne</creator><creator>Valkenburg, Sophie A</creator><creator>Hsu, Tzu-Yun</creator><creator>Zheng, Jian Teddy</creator><creator>Tu, Wenwei</creator><creator>Bruzzone, Roberto</creator><creator>Peiris, Joseph Sriyal Malik</creator><creator>Hsieh, Shie-Liang</creator><creator>Yen, Hui-Ling</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2493-3609</orcidid></search><sort><creationdate>20170101</creationdate><title>CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo</title><author>Teng, Ooiean ; Chen, Szu-Ting ; Hsu, Tsui-Ling ; Sia, Sin Fun ; Cole, Suzanne ; Valkenburg, Sophie A ; Hsu, Tzu-Yun ; Zheng, Jian Teddy ; Tu, Wenwei ; Bruzzone, Roberto ; Peiris, Joseph Sriyal Malik ; Hsieh, Shie-Liang ; Yen, Hui-Ling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-722ab3f2ffcdc06e720f90313e73cc5c57fe264c47254a207686aa9730246f7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Antibodies - pharmacology</topic><topic>Chemokine CXCL10 - genetics</topic><topic>Chemokine CXCL10 - immunology</topic><topic>Gene Expression Regulation</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - genetics</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - immunology</topic><topic>Host-Pathogen Interactions</topic><topic>Humans</topic><topic>Influenza A Virus, H1N1 Subtype - growth & development</topic><topic>Influenza A Virus, H1N1 Subtype - immunology</topic><topic>Influenza A Virus, H1N1 Subtype - pathogenicity</topic><topic>Influenza A Virus, H5N1 Subtype - growth & development</topic><topic>Influenza A Virus, H5N1 Subtype - immunology</topic><topic>Influenza A Virus, H5N1 Subtype - pathogenicity</topic><topic>Interferon-alpha - genetics</topic><topic>Interferon-alpha - immunology</topic><topic>Lectins, C-Type - antagonists & inhibitors</topic><topic>Lectins, C-Type - genetics</topic><topic>Lectins, C-Type - immunology</topic><topic>Lentivirus - genetics</topic><topic>Lentivirus - immunology</topic><topic>Lung - drug effects</topic><topic>Lung - immunology</topic><topic>Lung - virology</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - virology</topic><topic>Macrophages, Alveolar - drug effects</topic><topic>Macrophages, Alveolar - immunology</topic><topic>Macrophages, Alveolar - virology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Orthomyxoviridae</topic><topic>Orthomyxoviridae Infections - genetics</topic><topic>Orthomyxoviridae Infections - immunology</topic><topic>Orthomyxoviridae Infections - mortality</topic><topic>Orthomyxoviridae Infections - virology</topic><topic>Pathogenesis and Immunity</topic><topic>Primary Cell Culture</topic><topic>Protein Binding</topic><topic>Protein Isoforms - genetics</topic><topic>Protein Isoforms - immunology</topic><topic>Receptors, Cell Surface - antagonists & inhibitors</topic><topic>Receptors, Cell Surface - genetics</topic><topic>Receptors, Cell Surface - immunology</topic><topic>RNA, Small Interfering - genetics</topic><topic>RNA, Small Interfering - metabolism</topic><topic>Survival Analysis</topic><topic>Toll-Like Receptor 3 - genetics</topic><topic>Toll-Like Receptor 3 - immunology</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teng, Ooiean</creatorcontrib><creatorcontrib>Chen, Szu-Ting</creatorcontrib><creatorcontrib>Hsu, Tsui-Ling</creatorcontrib><creatorcontrib>Sia, Sin Fun</creatorcontrib><creatorcontrib>Cole, Suzanne</creatorcontrib><creatorcontrib>Valkenburg, Sophie A</creatorcontrib><creatorcontrib>Hsu, Tzu-Yun</creatorcontrib><creatorcontrib>Zheng, Jian Teddy</creatorcontrib><creatorcontrib>Tu, Wenwei</creatorcontrib><creatorcontrib>Bruzzone, Roberto</creatorcontrib><creatorcontrib>Peiris, Joseph Sriyal Malik</creatorcontrib><creatorcontrib>Hsieh, Shie-Liang</creatorcontrib><creatorcontrib>Yen, Hui-Ling</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teng, Ooiean</au><au>Chen, Szu-Ting</au><au>Hsu, Tsui-Ling</au><au>Sia, Sin Fun</au><au>Cole, Suzanne</au><au>Valkenburg, Sophie A</au><au>Hsu, Tzu-Yun</au><au>Zheng, Jian Teddy</au><au>Tu, Wenwei</au><au>Bruzzone, Roberto</au><au>Peiris, Joseph Sriyal Malik</au><au>Hsieh, Shie-Liang</au><au>Yen, Hui-Ling</au><au>Perlman, Stanley</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>91</volume><issue>1</issue><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>Human infections with influenza viruses exhibit mild to severe clinical outcomes as a result of complex virus-host interactions. Induction of inflammatory mediators via pattern recognition receptors may dictate subsequent host responses for pathogen clearance and tissue damage. We identified that human C-type lectin domain family 5 member A (CLEC5A) interacts with the hemagglutinin protein of influenza viruses expressed on lentiviral pseudoparticles through lectin screening. Silencing CLEC5A gene expression, blocking influenza-CLEC5A interactions with anti-CLEC5A antibodies, or dampening CLEC5A-mediated signaling using a spleen tyrosine kinase inhibitor consistently reduced the levels of proinflammatory cytokines produced by human macrophages without affecting the replication of influenza A viruses of different subtypes. Infection of bone marrow-derived macrophages from CLEC5A-deficient mice showed reduced levels of tumor necrosis factor alpha (TNF-α) and IP-10 but elevated alpha interferon (IFN-α) compared to those of wild-type mice. The heightened type I IFN response in the macrophages of CLEC5A-deficient mice was associated with upregulated TLR3 mRNA after treatment with double-stranded RNA. Upon lethal challenges with a recombinant H5N1 virus, CLEC5A-deficient mice showed reduced levels of proinflammatory cytokines, decreased immune cell infiltration in the lungs, and improved survival compared to the wild-type mice, despite comparable viral loads noted throughout the course of infection. The survival difference was more prominent at a lower dose of inoculum. Our results suggest that CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo and may be considered a therapeutic target in combination with effective antivirals. Well-orchestrated host responses together with effective viral clearance are critical for optimal clinical outcome after influenza infections.
Multiple pattern recognition receptors work in synergy to sense viral RNA or proteins synthesized during influenza replication and mediate host responses for viral control. Well-orchestrated host responses may help to maintain the inflammatory response to minimize tissue damage while inducing an effective adaptive immune response for viral clearance. We identified that CLEC5A, a C-type lectin receptor which has previously been reported to mediate flavivirus-induced inflammatory responses, enhanced induction of proinflammatory cytokines and chemokines in myeloid cells after influenza infections. CLEC5A-deficient mice infected with influenza virus showed reduced inflammation in the lungs and improved survival compared to that of the wild-type mice despite comparable viral loads. The survival difference was more prominent at a lower dose of inoculum. Collectively, our results suggest that dampening CLEC5A-mediated inflammatory responses in myeloid cells reduces immunopathogenesis after influenza infections.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>27795434</pmid><doi>10.1128/JVI.01813-16</doi><orcidid>https://orcid.org/0000-0003-2493-3609</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-538X |
ispartof | Journal of virology, 2017-01, Vol.91 (1) |
issn | 0022-538X 1098-5514 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5165214 |
source | MEDLINE; PubMed Central; EZB Electronic Journals Library |
subjects | Animals Antibodies - pharmacology Chemokine CXCL10 - genetics Chemokine CXCL10 - immunology Gene Expression Regulation Hemagglutinin Glycoproteins, Influenza Virus - genetics Hemagglutinin Glycoproteins, Influenza Virus - immunology Host-Pathogen Interactions Humans Influenza A Virus, H1N1 Subtype - growth & development Influenza A Virus, H1N1 Subtype - immunology Influenza A Virus, H1N1 Subtype - pathogenicity Influenza A Virus, H5N1 Subtype - growth & development Influenza A Virus, H5N1 Subtype - immunology Influenza A Virus, H5N1 Subtype - pathogenicity Interferon-alpha - genetics Interferon-alpha - immunology Lectins, C-Type - antagonists & inhibitors Lectins, C-Type - genetics Lectins, C-Type - immunology Lentivirus - genetics Lentivirus - immunology Lung - drug effects Lung - immunology Lung - virology Macrophages - drug effects Macrophages - immunology Macrophages - virology Macrophages, Alveolar - drug effects Macrophages, Alveolar - immunology Macrophages, Alveolar - virology Mice Mice, Inbred C57BL Mice, Knockout Orthomyxoviridae Orthomyxoviridae Infections - genetics Orthomyxoviridae Infections - immunology Orthomyxoviridae Infections - mortality Orthomyxoviridae Infections - virology Pathogenesis and Immunity Primary Cell Culture Protein Binding Protein Isoforms - genetics Protein Isoforms - immunology Receptors, Cell Surface - antagonists & inhibitors Receptors, Cell Surface - genetics Receptors, Cell Surface - immunology RNA, Small Interfering - genetics RNA, Small Interfering - metabolism Survival Analysis Toll-Like Receptor 3 - genetics Toll-Like Receptor 3 - immunology Tumor Necrosis Factor-alpha - genetics Tumor Necrosis Factor-alpha - immunology |
title | CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T20%3A24%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CLEC5A-Mediated%20Enhancement%20of%20the%20Inflammatory%20Response%20in%20Myeloid%20Cells%20Contributes%20to%20Influenza%20Virus%20Pathogenicity%20In%20Vivo&rft.jtitle=Journal%20of%20virology&rft.au=Teng,%20Ooiean&rft.date=2017-01-01&rft.volume=91&rft.issue=1&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.01813-16&rft_dat=%3Cproquest_pubme%3E1868304088%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1834999854&rft_id=info:pmid/27795434&rfr_iscdi=true |